ebook Munafa Stock Market Course + Intraday & FNO calls  

       

526953 announcements Venus Remedi announcements and dividends declared BSE

Venus Remedi Complete list of announcements declared & dividend announcements by Venus Remedi 526953

Venus Remedi 526953 listed on BSE and deals in

Announcements and dividends declared by Venus Remedi 526953

Venus Remedies gets marketing authorisation from Philippines, Saudi Arabia for three oncology drugs
Pharma major Venus Remedies on Wednesday said it has received marketing authorisation from Philippines and Saudi Arabia for three oncology drugs. In a statement, the Panchkula-based company said it has received regulatory approval from Philippines, the sec
Announcement as on 06 December 2023

Venus Remedies zooms 20%; gets nod for 6 chemotherapy drugs in Philippines
The company has secured marketing authorisation for bortezomib cisplatin, doxorubicin, docetaxel, flurouracil and paclitaxel from the Philippines.
Announcement as on 16 October 2023

Venus Remedies gains 4% on Philippine nod to market 6 chemotherapy drugs
Venus Remedies has already submitted dossiers to the Health Ministry of the Philippines movement for another 45 marketing authorisations, and most of these pending approvals are for oncology product.
Announcement as on 16 October 2023

Venus Remedies gets marketing approval for six chemotherapy drugs from Philippines
Venus Remedies has already submitted dossiers to the Health Ministry of the Philippines for additional 45 marketing authorisations, and most of these pending approvals are for oncology products, it said. Pertinently, the market size of cancer drugs in the
Announcement as on 16 October 2023

Venus Remedies trades 2% up on approval to market cancer drugs in Serbia
"The company has secured marketing authorisation from Serbia for gemcitabine and docetaxel, widely used chemotherapy drugs beneficial in the treatment of various types of cancer," the company said in a regulatory filing.
Announcement as on 20 September 2023

Announcements by Venus Remedi first page | Next page | Prev page |

526953 Venus Remedi current price & indicator signals

Moving Averages for Venus Remedi

  • 5Day Average: 867.76
  • 12Day Average: 873.02
  • 20Day Average: 838.72
  • 50Day Average: 782.81
  • 100Day Average: 749.77
  • 150Day Average: 650.87
  • 200Day Average: 608.14

526953 Indicators & signals

Indicator MACD (12,26,9)

858.56, 828.22, 31.06
Indicator MACD is in positive zone

Indicator ADX (14)

23.27, 28.89, 17.98
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 54
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 526953 Venus Remedi are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
02 Thu Apr 2026 897.40 844.00 to 908.35 3.73% 4.35 times
01 Wed Apr 2026 865.10 830.10 to 866.85 4.78% 1.98 times
30 Mon Mar 2026 825.60 825.60 to 857.05 -5% 0.53 times
27 Fri Mar 2026 869.05 846.80 to 900.00 -1.43% 0.42 times
25 Wed Mar 2026 881.65 874.00 to 908.10 1.94% 0.94 times
24 Tue Mar 2026 864.90 823.75 to 864.90 5% 0.86 times
23 Mon Mar 2026 823.75 823.70 to 870.50 -4.99% 0.78 times
20 Fri Mar 2026 867.05 855.00 to 900.00 1.11% 0.95 times
19 Thu Mar 2026 857.55 851.05 to 915.00 -4.27% 1.13 times
18 Wed Mar 2026 895.80 870.00 to 936.80 -2.15% 1.27 times
17 Tue Mar 2026 915.50 907.65 to 950.00 0.29% 1.15 times
16 Mon Mar 2026 912.85 879.25 to 938.75 2.1% 0.77 times

Videos related to: 526953 announcements Venus Remedi announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

526953 announcements Venus Remedi announcements and dividends declared BSE

 

Back to top